Page last updated: 2024-09-02

liquiritigenin and Alzheimer Disease

liquiritigenin has been researched along with Alzheimer Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Guan, L; Jia, J; Jiang, H; Peng, D; Zhang, L1
Du, Y; He, G; Luo, M; Wang, K; Xu, M; Yao, Q1
Fu, Y; Link, P; Wetterauer, B; Wink, M1
Fu, JY; Liu, RT; Lu, QJ; Tang, JT; Zou, LB1

Other Studies

4 other study(ies) available for liquiritigenin and Alzheimer Disease

ArticleYear
Design, synthesis, and cholinesterase inhibition assay of liquiritigenin derivatives as anti-Alzheimer's activity.
    Bioorganic & medicinal chemistry letters, 2021, 11-15, Volume: 52

    Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cell Line; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship

2021
Liquiritigenin Decreases Aβ Levels and Ameliorates Cognitive Decline by Regulating Microglia M1/M2 Transformation in AD Mice.
    Neurotoxicity research, 2021, Volume: 39, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line, Tumor; Cognitive Dysfunction; Disease Models, Animal; Encephalitis; Female; Flavanones; Mice, Transgenic; Microglia

2021
Extracts of Glycyrrhiza uralensis and isoliquiritigenin counteract amyloid-β toxicity in Caenorhabditis elegans.
    Planta medica, 2015, Volume: 81, Issue:5

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Chalcones; Flavanones; Glycyrrhetinic Acid; Glycyrrhiza uralensis; Glycyrrhizic Acid; Humans; Phytotherapy; Plant Extracts

2015
Liquiritigenin attenuates the learning and memory deficits in an amyloid protein precursor transgenic mouse model and the underlying mechanisms.
    European journal of pharmacology, 2011, Nov-01, Volume: 669, Issue:1-3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Astrocytes; Avoidance Learning; CA1 Region, Hippocampal; Disease Models, Animal; Female; Flavanones; Glial Fibrillary Acidic Protein; Gliosis; Learning; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Nootropic Agents; Receptor, Notch2

2011